CHU Hopital Michallon

Grenoble 38043

0 studies enrolling now · 3 studies all time

What they study most

Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients., B-cell Chronic Lymphocytic Leukemia, Heart Failure NYHA Class III and Ambulatory IV

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication — Completed